Learn more about Clayas weight loss treatment programs, including compounded semaglutide for medically supervised weight loss.
Innovent Biologics
When you are well enough, you can reach out to our Miami Zepbound lawsuit lawyers for a free case review
Twice-weekly glepaglutide significantly beat placebo at reducing patients parenteral support needs, though the once-weekly dosing regimen failed to achieve statistical significance
Serious but rare risks requiring immediate medical attention (call 999 or go to A&E if severe) include: Severe, persistent abdominal pain (potential pancreatitis) Signs of gallbladder problems (pain in upper right abdomen, fever, yellowing of skin or eyes) Chest pain, severe palpitations, or shortness of breath Severe mood changes or psychotic symptoms (more commonly associated with stimulants) Signs of severe dehydration or acute kidney injury Patients with pre-existing conditions require particular caution, including those with cardiovascular disease, history of pancreatitis, gallbladder disease, eating disorders, psychiatric conditions, or substance use history
Your healthcare provider will have to inform Cigna that you have performed behavioral modifications (e.g., increasing exercise) and a reduced-calorie diet for at least three months, and have either: A BMI of 30 or higher, or A BMI of 27 or higher, plus a weight-related comorbidity approved by Cigna, such as hypertension, Type 2 diabetes, dyslipidemia (high cholesterol), obstructive sleep apnea, or cardiovascular disease Wegovy is also FDA approved for cardiovascular risk reduction
